Please login to the form below

Not currently logged in
Email:
Password:

ReNeuron

This page shows the latest ReNeuron news and features for those working in and with pharma, biotech and healthcare.

ReNeuron aiming to take second stem cell therapy into clinic

ReNeuron aiming to take second stem cell therapy into clinic

ReNeuron aiming to take second stem cell therapy into clinic. Will test its human retinal progenitor cell for genetic eye disease RP. ... ReNeuron is already conducting trials of a neural stem cell product called CTX in stroke (phase II) and critical

Latest news

  • ReNeuron wins orphan status for stem cell therapy ReNeuron wins orphan status for stem cell therapy

    ReNeuron wins orphan status for stem cell therapy. ReN003 is being assessed as a treatment for rare eye disorder retinitis pigmentosa. ... ReNeuron's investigational stem cell therapy has received orphan status in the EU and US for use in a rare eye

  • Government funding brings ReNeuron to Wales Government funding brings ReNeuron to Wales

    Government funding brings ReNeuron to Wales. Stem cell specialist moves from former base in England. ... Stem cell specialist ReNeuron will shift its operations from England to Wales on the back of an equity investment and funding by the Welsh government.

  • ReNeuron and Schepens stem cell patent

    ReNeuron and Schepens stem cell patent. ReNeuron Group has signed a patent and know-how license agreement with Schepens Eye Research Institute. ... our collaboration with ReNeuron under this new agreement, bringing us closer to the day when blindness can

  • Switched on

    Meanwhile, in the UK, ReNeuron is moving forward with testing a stem cell therapy for stroke (ReN001).

  • R&D News in brief

    One of Merlin's investments, ReNeuron, which is developing stem cell-based therapies for people paralysed by a stroke, recently raised money on the stock exchange.

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Glythera appoints Dr Mike Owen Glythera appoints Dr Mike Owen

    Owen is also currently a director of Avacata plc, Blink Biomedical SAS, GammDelta Therapeutics, Ossianix Inc, ReNeuron plc and Zealand Pharma A/S.

  • ReNeuron makes shifts and additions to senior team ReNeuron makes shifts and additions to senior team

    ReNeuron makes shifts and additions to senior team. Including Sharon Grimster being named as general manager for Wales. ... UK-based stem cell therapy company ReNeuron has announced a number of board and senior management changes.

  • ReNeuron appoints new CEO ReNeuron appoints new CEO

    Michael Hunt, who has held the position of CEO since July 2005, will remain on ReNeuron's Board as chief financial officer. ... Bryan Morton, chairman of ReNeuron, commented: “ I am delighted to welcome Olav Hellebø to the role of chief executive

  • Simbec appoints ex-ABPI DG as chairman Simbec appoints ex-ABPI DG as chairman

    Earlier this week, ReNeuron stated that the Fund was behind its move from England to Wales, and Sir Chris said that Simbec's appointment of Prof Jones was further evidence for

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

    Meet the CEO behind ReNeuron’ s cutting-edge stem cell therapies. Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’ s latest innovation in ... Image: Olav Hallebo, CEO, ReNeuron. The global stem cell market

  • How do you define a biotech company?

    ReNeuron, a leading, clinical-stage stem cell business.

  • Blue Latitude Health

    Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’ s latest innovation in stem cell therapy and to learn his perspective on navigating the

  • Latest white papers and resources

    Submitted by: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’ s latest innovation in stem cell therapy and to learn his perspective on

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics